KRAS Isoform B Coupled Nucleotide Exchange Assay Kit

Catalog #
78583
$1,355 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The KRAS IsoformB Coupled Nucleotide Exchange Assay Kit is designed for screening and profiling of KRAS IsoformB antagonists/inhibitors by monitoring the binding of an effector protein such as the Ras binding domain of Raf1, (RBD-cRaf) to KRAS. With this kit, a few simple steps on a microtiter plate are required for nucleotide exchange detection. First, a sample containing GDP-loaded KRAS Isoform B is incubated with SOS1 and GTP for the nucleotide exchange. Next, RBD-cRAF is added and incubated for the 
effector-RAS binding. Then, acceptor and donor beads are added and incubated for detection followed by reading the Alpha-counts.

SOS1(son of sevenless)is a guanine nucleotide exchange factor that facilitates the exchange of GDP for GTP. GDP-loaded KRAS Isoform B is in an inactive state and does not interact with the Ras-binding domain (RBD) of cRAF. SOS1 assists in the release of GDP from KRAS Isoform B so that GTP can occupy the nucleotide binding pocket. This results in a conformational change in KRAS IsoformB that permits its binding to RBD-cRAF. The KRAS IsoformB Coupled Nucleotide Exchange Assay Kit utilizes GST-tagged RBD-cRAF and His-tagged KRAS Isoform B to assay binding of KRAS to RBD-cRAF in the Alpha assay. Glutathione acceptor and Ni chelate donor beads are brought into proximal range by the binding of KRAS and RBD-cRAF, enabling the energy transfer from the donor to acceptor beads after laser excitation.

Figure 1: Illustration of the assay principle. 

Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Supplied As
The KRAS IsoformB Coupled Nucleotide Exchange Assay Kit comes in a convenient 384-well format, with enough purified recombinant GDP-loaded KRAS Isoform B, GTP, exchange factor SOS1, an effector protein RBD-cRAF, assay buffer and additives for 400 reactions.
Materials Required But Not Supplied
Name Ordering Information
AlphaLISA® Glutathione acceptor beads, 5 mg/ml PerkinElmer #AL109C
AlphaScreen® Nickel Chelate donor beads, 5 mg/ml PerkinElmer #AS101D
Optiplate - 384 PerkinElmer #6007290 
AlphaScreen® microplate reader  
Adjustable micropipettor and sterile tips   

 

Format
Catalog # Name Amount Storage
101522 GDP-loaded KRAS Isofrom B,His-Tag* 5 µg -80°C
101573 SOS1, FLAG-Tag* 50 µg -80°C
100519 RBD-cRAF, GST-Tag* 5 µg -80°C
79861-2 GTP (10 mM)  0.5 ml -20°C
  RBD-RAS Binding Buffer(Incomplete) 2 x 3 ml -20°C
  DTT (0.5 M)  2 x 200 µl -20°C
79311  3x Immuno Buffer 1 4 ml -20°C

*The concentration of the protein is lot-specific and will be indicated on the tube

UniProt #
P01116
Background

High levels of wild-type KRAS cause a slowing of cell replication and growth, and increased apoptosis. This can be induced by cellular stress, certain types of radiation, chemical signals, and other prompts. Wild-type KRAS may also protect against mutant KRAS over-activation by dimerizing with mutant KRAS protein.

The study of differences in the behavior of the wild-type and mutated forms of KRAS is especially important since KRAS mutations are responsible for more than 30% of human cancers. Compounds that affect the nucleotide exchange (GDP to GTP) reaction provide a novel approach to the inhibition of tumor cell growth in KRAS-driven tumors. In 2021, the Food and Drug Administration granted approval for use of AMG510 (Sotorasib), a potent KRAS G12C inhibitor for non-squamous non-small cell lung cancer.